Cancer metastasis networks and the prediction of progression patterns

British Journal of Cancer

Volumn 101, Issue 5, 2009, Pages 749-758

  Chen, L L ^a   Blumm, N ^b   Christakis, N A ^c   Barabasi A L ^b,d   Deisboeck, T S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Comorbidity networks; Metastasis; Prediction; Progression

Indexed keywords

AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER LOCALIZATION; CANCER PATIENT; COMORBIDITY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MEDICARE; METASTASIS; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL;

AGED; ALGORITHMS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 70249104257     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605214     Document Type: Article

References (45)

1. Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 3: 74-85
2. Aggarwal A, Li Guo D, Hoshida Y, Tsan Yuen S, Chu KM, So S, Boussioutas A, Chen X, Bowtell D, Aburatani H (2006) Topological and functional discovery in a gene coexpression meta-network of gastric cancer. Cancer Res 66: 232-241
3. Barabasi AL (2007) Network medicine-from obesity to the ?diseasome?. N Engl J Med 357: 404-407
4. Barry MJ (2001) Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med 344: 1373-1377
5. Chambers AF, Groom AC, MacDonald IC (2002) Metastasis: dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572
6. Christakis NA, Allison PD (2006) Mortality after the hospitalization of a spouse. N Engl J Med 354: 719-730
7. Cooper GS, Yuan Z, Stange KC, Dennis LK, Amini SB, Rimm AA (1999) The sensitivity of Medicare claims data for case ascertainment of six common cancers. Med Care 37: 436-444
8. Disibio G, French SW (2008) Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med 132: 931-939
9. Dougall WC, Chaisson M (2006) The RANK/RANKL/OPG triad in cancer-induced bone diseases. Cancer Metastasis Rev 25: 541-549
10. Fearon ER (1997) Human cancer syndromes: clues to the origin and nature of cancer. Science 278: 1043-1050
11. Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38: 2651-2660
12. Fidler IJ (2003) The pathogenesis of cancer metastasis: the ?seed and soil? hypothesis revisited. Nat Rev Cancer 3: 453-458
13. Fisher ES, Baron JA, Malenka DJ, Barrett J, Bubolz TA (1990) Overcoming potential pitfalls in the use of Medicare data for epidemiologic research. Am J Public Health 80: 1487-1490
14. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL (2007) The human disease network. Proc Natl Acad Sci USA 104: 8685-8690
15. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537
16. Gupta GP, Massagué J (2006) Cancer metastasis: building a framework. Cell 127: 679-695
17. Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY (2008) Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 9: 222-231
18. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70
19. Hart IR (1982) Seed and soil revisited mechanisms of site specific metastasis. Cancer Metastasis Rev 1: 5-16
20. Hatten J (1980) Medicare?s common denominator: the covered population. Health Care Financ Rev 2: 53-64
21. Hennessy S, PharmD PD, Leonard CE, Palumbo CM, Newcomb C, Bilker WB (2007) Quality of Medicaid and Medicare data obtained through Centers for Medicare and Medicaid Services (CMS). Med Care 45: 1216-1220
22. Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL (2006) Metastatic patterns in adenocarcinoma. Cancer 106: 1624-1633
23. Hidalgo CA, Blumm N, Barabási AL, Christakis NA (2009) A dynamic network approach for the study of human phenotypes. PLoS Comput Biol 5: e1000353
24. Holmgren L, O?Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1: 149-153
25. Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud Ø, Gjertsen BT, Nolan GP (2004) Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118: 217-228
26. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer Statistics, 2008. CA Cancer J Clin 58: 71-96
27. Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I, Morony S, Rubin E, Sarao R, Hojilla CV (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440: 692-696
28. Landon BE, Zaslavsky AM, Bernard SL, Cioffi MJ, Cleary PD (2004) Comparison of performance of traditional Medicare vs Medicare managed care. JAMA 291: 1744-1752
29. Lee DS, Park J, Kay KA, Christakis NA, Oltvai ZN, Barabási AL (2008) The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci USA 105: 9880-9885
30. Loscalzo J, Kohane I, Barabasi AL (2007) Human disease classification in the postgenomic era: a complex systems approach to human pathobiol-ogy. Mol Syst Biol 3: 124
31. Mitchell JB, Bubolz T, Paul JE, Pashos CL, Escarce JJ, Muhlbaier LH, Wiesman JM, Young WW, Epstein RS, Javitt JC (1994) Using Medicare claims for outcomes research. Med Care 32: 51
32. Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1: 99-101
33. Pantel K, Cote RJ, Fodstad O (1999) Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91: 1113-1124
34. Peer PG, van Dijck JA, Hendriks JH, Holland R, Verbeek AL (1993) Age-dependent growth rate of primary breast cancer. Cancer 71: 3547-3551
35. Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350: 1655-1664
36. Sporn MB (1996) The war on cancer. Lancet 347: 1377-1381
37. Surján G (1999) Questions on validity of International Classification of Diseases-coded diagnoses. Int J Med Inform 54: 77-95
38. Tavazoie S, Hughes JD, Campbell MJ, Cho RJ, Church GM (1999) Systematic determination of genetic network architecture. Nat Genet 22: 281-285
39. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408: 307-310
40. Weiss L (1992) Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin Exp Metastasis 10: 191-199
41. Weiss L, Harlos JP, Torhorst J, Gunthard B, Hartveit F, Svendsen E, Huang WL, Grundmann E, Eder M, Zwicknagl M (1988) Metastatic patterns of renal carcinoma: an analysis of 687 necropsies. J Cancer Res Clin Oncol 114: 605-612
42. Yoneda T (1998) Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 34: 240-245
43. Yoneda T, Hiraga T (2005) Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun 328: 679-687
44. Zetter BR (1990) The cellular basis of site-specific tumor metastasis. N Engl J Med 322: 605-612
45. Zhang JX, Iwashyna TJ, Christakis NA (1999) The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims. Med Care 37: 1128-1139